What Is Genetic Screening?
Genetic screening looks for genetic or chromosomal differences associated with particular medical conditions.
Screening can be performed before conception, during pregnancy, during IVF, after birth, or later in life. It may help individuals prepare for medical needs, pursue further testing, or make reproductive decisions.
A screening result usually estimates risk. It does not necessarily establish that a condition is present.
Screening Versus Diagnosis
| Genetic screening | Diagnostic testing |
|---|---|
| Estimates the likelihood of a condition | Determines whether a specific condition is present |
| Can produce false-positive or false-negative results | Generally provides a more definitive result |
| Often performed on blood, saliva, or ultrasound findings | May require a tissue or fluid sample |
| May indicate that additional testing should be considered | Can confirm or rule out the suspected condition |
For example, prenatal cell-free DNA testing screens for an increased likelihood of certain chromosomal conditions, including Down syndrome. A positive result should generally be followed by diagnostic testing through chorionic villus sampling or amniocentesis before major medical decisions are made.
Types of Genetic Screening
Carrier Screening
Carrier screening determines whether a person carries a genetic variant that could be passed to a child.
A carrier may have no symptoms but could have a child with the condition if the other biological parent carries a related variant.
Prenatal Genetic Screening
Prenatal screening estimates whether a fetus has an increased likelihood of certain genetic or chromosomal conditions.
Common methods include:
- Maternal blood screening
- Cell-free DNA screening
- Ultrasound measurements
- Screening for neural tube defects
- Combined first-trimester or second-trimester screening
Preimplantation Genetic Testing
Preimplantation genetic testing, or PGT, is performed on embryos created through IVF before they are transferred to the uterus.
Embryos may be screened for:
- Chromosomal abnormalities
- Specific inherited disorders
- Sex-linked conditions
- Certain genetic variants associated with future disease
Embryos with identified conditions may not be transferred and may instead remain frozen, be donated for research, or be discarded.
Newborn Screening
Newborn screening tests infants shortly after birth for conditions that may benefit from early treatment.
Unlike screening intended to guide decisions about whether a child should be born, newborn screening seeks to identify medical needs so that the child can receive timely care.
Potential Benefits
Genetic screening can provide valuable information when used responsibly.
It may help families:
- Prepare for a child’s medical needs
- Arrange delivery at an appropriate medical facility
- Begin treatment shortly after birth
- Learn about inherited conditions
- Obtain genetic counseling
- Make informed healthcare decisions
- Connect with specialists and support organizations
Genetic knowledge is not inherently opposed to pro-life ethics. The ethical concern is how the information is obtained, interpreted, and used.
Ethical Issues
Screening Is Not a Diagnosis
Parents may misunderstand a positive screening result as proof that their child has a condition.
False-positive and false-negative results are possible. Some findings also involve uncertain severity or incomplete penetrance, meaning that a person with the genetic variant may never develop the condition or may experience it very differently from others.
Making an irreversible decision based only on screening can result in the abortion or destruction of an embryo who did not have the suspected condition.
Informed Consent
Genetic screening is sometimes presented as a routine part of care rather than a meaningful choice.
Patients may agree without understanding:
- What conditions are being screened for
- How accurate the test is
- What a positive result means
- Whether confirmation is needed
- What decisions may follow
- Whether unexpected information could be discovered
Ethical screening requires voluntary and informed consent. Patients should also have the right to decline testing. Current ACOG guidance recognizes a patient’s right to accept or decline prenatal screening and diagnostic testing.
Disability Discrimination
Prenatal screening can encourage society to view disability primarily as something to prevent by preventing the birth of people who have it.
This is sometimes called the expressivist objection. The concern is that selectively aborting children with Down syndrome or other conditions communicates that lives with those conditions are less valuable.
Screening may also reduce a person to one characteristic. A diagnosis can become the defining fact about the child while the child’s relationships, personality, abilities, and possible quality of life receive less attention.
Disability advocates have warned that widespread selection may increase stigma and weaken social support for people living with the conditions being screened for.
Pressure to Abort
Prenatal screening is often described as neutral information. In practice, parents may experience direct or indirect pressure to abort after receiving a concerning result.
Pressure may come from:
- Healthcare professionals
- Family members
- Financial concerns
- Fear of inadequate support
- Negative or outdated descriptions of disability
- The assumption that testing is pointless unless abortion is considered
True informed consent requires balanced information about the condition, available treatment, adoption, parenting, palliative care, and support services.
Embryo Selection and Destruction
Preimplantation genetic testing raises additional ethical concerns because it is used to rank embryos before transfer.
Embryos identified as having a genetic condition may be excluded from transfer, indefinitely frozen, used in research, or discarded.
The pro-life position holds that each embryo is already a living human organism. Screening embryos to determine which will be allowed to continue developing therefore differs morally from testing intended to provide medical treatment.
Sex and Trait Selection
Genetic technology can be used for purposes beyond preventing severe disease.
It may permit selection based on:
- Biological sex
- Adult-onset disease risks
- Predicted physical characteristics
- Polygenic estimates of intelligence, height, or other traits
This raises concerns about sex discrimination, parental expectations, inequality, and a renewed form of eugenics.
The more children are selected according to preferred characteristics, the greater the risk that they will be treated as designed products rather than persons received and loved without conditions.
Privacy and Discrimination
Genetic results can reveal information not only about the person tested but also about biological relatives.
Questions may arise concerning:
- Who can access the results
- Whether relatives should be informed
- How information is stored
- Whether insurers or employers could misuse it
- Whether children should be tested for adult-onset conditions
- Whether a person has a right not to know certain genetic risks
Unequal Access
Genetic screening and IVF technologies can be expensive. Unequal access may allow wealthier families greater control over reproductive outcomes while directing public resources away from treatment and support for people already living with disabilities.
The Pro-Life Perspective
The pro-life position does not reject genetic knowledge or responsible medical testing.
Screening can be morally valuable when it is used to:
- Prepare for a child’s birth
- Provide treatment
- Choose an appropriate delivery plan
- Support the child and family
- Reduce suffering without intentionally causing death
The ethical problem arises when screening is used to determine which human beings should be permitted to live.
A diagnosis describes a condition. It does not measure the worth of the person who has it. A child’s dignity does not depend on health, ability, independence, or a favorable genetic profile.
Why Genetic Screening Matters
Genetic screening can serve either care or selection.
Used as a medical tool, it can help families understand and respond to a child’s needs. Used as a method of eliminating embryos or fetuses with unwanted characteristics, it can reinforce the belief that some human lives are less worthy of protection.
The central ethical question is not simply whether genetic information should be available. It is:
Will that information be used to care for the person or to prevent that person from being born?